Seegene develops PCR test to detect monkeypox virus

Assay targets monkeypox virus and can give results in 90 minutes

The company rapidly rolls out the product using its automated assay development system

"SeaGene will strive to accurately test for emerging viruses to help prevent future pandemics"

Seoul, South Korea, June 28, 2022 /PRNewswire/ -- Seegene, Inc. (KQ965390), South Korea's leading molecular diagnostics (MDx) company

A PCR test has been developed to detect the monkeypox virus.

The NovaPlex™ MPXV Assay, which specifically targets the monkeypox virus,

Rapidly developed using the company's AI-based automated test development system

, popularly known as SGDDS (SeaGene Digitalized Development System),

And the technologies are refined over 20 years of MDX expertise.

The World Health Organization says monkeypox virus is an "evolving health threat"

which requires collective attention and coordinated action," called on member states to step up surveillance, contact tracing and testing.

The monkeypox virus has been detected in more than 50 countries, with South Korea confirming its first case last week.

The strain currently circulating in the Northern Hemisphere has an estimated mortality rate of between 3-6 percent

And it's considered especially dangerous for children and people with weakened immune systems.

Dr. Jong-eun Chun, CEO of Seagene, said, "The monkeypox virus outbreak shows that endemic viruses can spread rapidly to the rest of the world

And this is a warning that a new pandemic could emerge at any time and put our lives at risk."

For more information click on the button below